Ann Arbor, MI, United States of America

Jeffrey Buis

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Nucleic Acid Detection by Jeffrey Buis

Introduction

Jeffrey Buis, an inventor based in Ann Arbor, MI, has made significant contributions to the field of molecular biology. With a total of four patents to his name, he has focused on developing innovative methods for counting nucleic acid molecules, which have profound implications in genetic research and diagnostics.

Latest Patents

Jeffrey Buis's latest patents are particularly noteworthy for their emphasis on improving techniques for the detection and quantification of nucleic acid molecules. One of his patents involves methods, systems, and compositions that enable the detection and quantification of variations in gene dosage. This technology addresses issues like gene duplication and chromosomal variations, such as trisomy, which can occur without the need for digital sequencing. His work is poised to enhance our understanding of genetic anomalies and improve diagnostic procedures in clinical settings.

Career Highlights

Throughout his career, Jeffrey has been associated with notable companies including Enumera Molecular, Inc. and Progenity, Inc. His experience in these organizations has allowed him to advance his research and contribute significantly to the field of molecular diagnostics. His work has not only encapsulated the technical aspects of invention but also the practical applications that cater to real-world problems in genetics.

Collaborations

Jeffrey has had the privilege of collaborating with esteemed colleagues in his field, such as Matthew Sekedat and Ronald David Beaubien, Jr. These collaborations have further fostered innovation and the development of technologies that can change the landscape of genetic research and diagnostics.

Conclusion

In conclusion, Jeffrey Buis is a prominent inventor whose innovative work in nucleic acid detection is paving the way for advancements in genetic research. His patents reflect a strong commitment to enhancing diagnostic methods and improving our understanding of genetic variations. As his work continues to evolve, it will likely lead to new frontiers in molecular biology and personalized medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…